IBDEI26B ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36868,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,36868,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,36869,0)
 ;;=L40.1^^137^1776^18
 ;;^UTILITY(U,$J,358.3,36869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36869,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,36869,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,36869,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,36870,0)
 ;;=L40.4^^137^1776^12
 ;;^UTILITY(U,$J,358.3,36870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36870,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,36870,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,36870,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,36871,0)
 ;;=L24.9^^137^1776^13
 ;;^UTILITY(U,$J,358.3,36871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36871,1,3,0)
 ;;=3^Irritant Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,36871,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,36871,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,36872,0)
 ;;=L30.0^^137^1776^14
 ;;^UTILITY(U,$J,358.3,36872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36872,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,36872,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,36872,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,36873,0)
 ;;=L40.8^^137^1776^15
 ;;^UTILITY(U,$J,358.3,36873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36873,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,36873,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,36873,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,36874,0)
 ;;=L30.8^^137^1776^9
 ;;^UTILITY(U,$J,358.3,36874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36874,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,36874,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,36874,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,36875,0)
 ;;=L40.0^^137^1776^16
 ;;^UTILITY(U,$J,358.3,36875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36875,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,36875,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,36875,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,36876,0)
 ;;=L40.9^^137^1776^17
 ;;^UTILITY(U,$J,358.3,36876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36876,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,36876,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,36876,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,36877,0)
 ;;=L40.3^^137^1776^19
 ;;^UTILITY(U,$J,358.3,36877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36877,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,36877,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,36877,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,36878,0)
 ;;=R21.^^137^1776^20
 ;;^UTILITY(U,$J,358.3,36878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36878,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,36878,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,36878,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,36879,0)
 ;;=L25.9^^137^1776^6
 ;;^UTILITY(U,$J,358.3,36879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36879,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,36879,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,36879,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,36880,0)
 ;;=M34.89^^137^1777^22
 ;;^UTILITY(U,$J,358.3,36880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36880,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,36880,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,36880,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,36881,0)
 ;;=M34.0^^137^1777^20
 ;;^UTILITY(U,$J,358.3,36881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36881,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,36881,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,36881,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,36882,0)
 ;;=F03.90^^137^1777^14
